Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Prostatic Neoplasms 3Toxemia 1Stomach Neoplasms 1Rectal Neoplasms 1Primary Ovarian Insufficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Pancreatic Neoplasms 1Neoplasms 1Myocarditis 1Muscle Weakness 1Hematologic Neoplasms 1Gastrointestinal Neoplasms 1Diabetes, Gestational 1Colonic Neoplasms 1Cardiovascular Diseases 1Breast Neoplasms 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

Radiosurgery 9Temozolomide 8Magnetic Resonance Spectroscopy 5pembrolizumab 4Specimen Handling 4Nivolumab 4Bevacizumab 4Receptors, Interleukin-8B 3Memantine 3trastuzumab deruxtecan 2abemaciclib 2Watchful Waiting 2Surveys and Questionnaires 2Radiotherapy 2Radiation 2Mental Status and Dementia Tests 2Ipilimumab 2Biopsy 2sotorasib 1sapanisertib 1sacituzumab govitecan 1ribociclib 1pertuzumab 1osimertinib 1lenvatinib 1fluciclovine F-18 1entrectinib 1elacestrant 1dexamethasone acetate 1dexamethasone 21-phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Positron-Emission Tomography × 30 days × Clear all
NCT06015295 2026-06-02

A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy

M.D. Anderson Cancer Center

Phase NA Active not recruiting
3 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡